BRIEF-Horizon CEO says appetite for M&A has not changed: Conf call
December 08, 2016 at 11:19 AM EST
* Horizon says studies testing Actimmune in cancer continue as planned - conf call
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.